Bio-Rad Laboratories BIO Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Bio-Rad Laboratories in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The official record: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Rad Laboratories's total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Rad Laboratories's total liabilities?
- Bio-Rad Laboratories (BIO) reported total liabilities of $2.94B in Q1 2026.
- How has Bio-Rad Laboratories's total liabilities changed year-over-year?
- Bio-Rad Laboratories's total liabilities increased by 3.2% year-over-year, from $2.85B to $2.94B.
- What is the long-term trend for Bio-Rad Laboratories's total liabilities?
- Over 5 years (2020 to 2025), Bio-Rad Laboratories's total liabilities has grown at a 0.2% compound annual growth rate (CAGR), from $3.09B to $3.12B.
- What does total liabilities mean?
- The sum of all money and obligations the company owes to outside parties.
- How do you interpret total liabilities?
- Rising total liabilities relative to assets may indicate increasing financial leverage and potential solvency risk.
- How does total liabilities compare across companies?
- A fundamental metric used to calculate debt-to-equity and leverage ratios across all sectors.